![]() Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
| ![]() Regulus Therapeutics Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs. | ||
Founding Date | Founding Date 2006 | Founding Date 2000 | Founding Date 2007 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ San Diego, US | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations San Diego, US HQ |
Employees | Employees 31019% decrease | Employees 999 | Employees 2462% decrease |
Valuation ($) | Valuation ($) 1.5 m | Valuation ($) 648.3 m | Valuation ($) 105.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) $62.8m (FY, 2022) | Revenue (est.) €53.8m (FY, 2023) | Revenue (est.) N/A |
Net income | Net income ($577.8m) (FY, 2022) | Net income (€260.2m) (FY, 2023) | Net income ($30m) (FY, 2023) |
Operating ⚠ | |||
Patents Issued | Patents Issued N/A | Patents Issued 233 (May, 2020) | Patents Issued 300 (FY, 2016) |
Funding | |||
Total funding raised | Total funding raised $ 42.6m | Total funding raised $ 1.1b | Total funding raised $ 10m |
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View companyRegulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
View company